fda compounding semaglutide enforcement 2025 news FDA's GLP-1 decision kicks off 'unprecedented' tussle over shortage Compounding pharmacies to halt semaglutide

Side Effects: Why Dose Strategy Matters GLP-1 medications can cause gastrointestinal side effects, especially during the first few weeks of treatment or after a dose increase

Stay Curious, Unbiased Science Want to support our work

Inject the BAC water against the inside wall of the vial do not aim the stream directly at the lyophilized cake

The pharmacy cannot or will not provide a Certificate of Analysis

Sales of the diabetes and weight loss drugs this year made Novo Nordisk Europe's most valuable company and Lilly the world's biggest pharmaceutical company

Easy quantitation of receptor activity by measuring luciferase activity High-throughput screening and profiling of inhibitors, blocking antibodies or activators for drug discovery Compliment with our Luciferase assay systems for sensitive and rapid detection of luciferase activity GLP-1R/CRE Luciferase Reporter HEK293 Cell Line GLP-1R/CRE Luciferase Reporter HEK293 Cell Line is an engineered HEK293 cell line expressing firefly luciferase under the control of cAMP response element (CRE), and human GLP-1R (Glucagon-like peptide 1 receptor